Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Apr 16, 2013
1
0
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Apr 16, 2013
1
0
US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.
Apr 10, 2013
0
0
(HealthDay News) —Prescription drug prices at U.S. pharmacies can vary widely, and failing to shop around could result in people overpaying by as much as $100 or more a month on average, depending on the drug, a new study ...
Mar 28, 2013
0
0
The commitment of Canadian premiers to lower generic drug prices is a major change in how the country prices generic drugs, and government should learn from past attempts, states an article published in CMAJ (Canadian Medical ...
Nov 19, 2012
0
0
(AP)—The Federal Trade Commission says it is mailing refund checks to 13,000 Medicare beneficiaries who were overcharged for drugs because a CVS Caremark Corp. business understated the price of the products.
Sep 4, 2012
0
1
The public oppose the cancer drugs fund but support the new pricing system for branded medicines, according to a new study.
Aug 16, 2012
0
0
(HealthDay) -- Even in the field of cancer treatment, sometimes newer isn't necessarily better.
Jun 4, 2012
0
0
Pfizer's patent on the best-selling drug of all-time, the cholesterol-lowering medication Lipitor, expired on Wednesday, opening the path to generic competitors for America's most popular medication.
Nov 30, 2011
1
0
Prior knowledge of phase III clinical trials of new drugs and Food and Drug Administration (FDA) regulatory decisions may affect the price of a drug company's stock according to a study published September 26 in the Journal ...
Sep 26, 2011
0
0